Australia Medical Device Registration

Several TGA medical device reclassification reforms include transitional arrangements. While certain reclassification applications remain subject to a 1 July 2026 transition deadline, other reforms have been extended until 1 July 2029. Manufacturers and sponsors should confirm the applicable transition deadline for their specific device classification before relying on existing ARTG entries.

Regulatory Authority

The Therapeutic Goods Administration (TGA) is Australia's national regulatory authority for therapeutic goods, including medical devices and in vitro diagnostic (IVD) medical devices. As part of the Australian Government Department of Health, Disability and Ageing, the TGA regulates the import, export, manufacture, supply, and advertising of therapeutic goods to help ensure they meet appropriate standards of safety, quality, and performance.

Link for Regulatory Authority

https://www.tga.gov.au/medical-devices-ivds

Local Regulation

• Therapeutic Goods (Medical Devices) Regulations 2002 ( https://www.tga.gov.au/resources/resource/guidance/australian-regulatory-guidelines-medical-devices-argmd )
• Therapeutic Goods Regulations 1990
• Therapeutic Goods Act 1989

The Legal and Institutional Framework

Medical devices in Australia are regulated by the Therapeutic Goods Administration (TGA), operating under the Department of Health and Aged Care, per the Therapeutic Goods Act 1989 and Therapeutic Goods (Medical Devices) Regulations 2002. Every device must be included in the Australian Register of Therapeutic Goods (ARTG) — the national registry for medicines, medical devices, biologicals, and related products — before it can legally be supplied, imported, or marketed, unless a specific exemption applies.

Classification of Medical Devices

• Class I – sterile or measuring function
• Class I – other (excluding export only devices)
• Class IIa
• Class IIb
• Class III

with Active Implantable Medical Devices forming their own distinct, highest-scrutiny category. Australian Medical Device  Classification rules are almost identical to EU classification criteria, and Medical Device classification  Australia will generally reflect EU treatment of the same device — though genuine exceptions exist, and these differences can limit your ability to leverage an existing EU CE certificate, or certificate or trigger a mandatory ARTG application audit you weren't expecting.

Listing or Registration Requirements

• A sponsor of a medical device must apply to the TGA to include their device on the Australian Register of Therapeutic Goods (ARTG).For very low risk devices, a sponsor can self-certify that their product meets the Essential Principles.
•  A Manufacturer Evidence application is not required for class 1 non-sterile, non-measuring medical devices.
• For Class I non-sterile, non-measuring devices, one must submit the manufacturer’s Declaration of Conformity with application for inclusion in the ARTG.
• A formal application is required for inclusion in the ARTG (Australian Register for therapeutic goods)an independent body must thoroughly assess the device and provide documents to show that the device meets the Essential Principles.
• If the device is a high-risk device (Class III or an Active Implantable Medical Device) the application must be selected for audit.
  The TGA will review the application and assess the device for safety, efficacy, and quality. Pay the applicable fee.

Documents Required for Australia Medical Device Registration

• Manufacturer Evidence for Medical Devices: This is submitted before applying and demonstrates the manufacturer’s quality management system.
• Conformity Assessment Document: This document shows the device meets Australian regulatory Body  requirements. It could be a TGA certificate, overseas approval evidence, or a declaration of conformity.
• Declaration of Conformity (DoC): This is a manufacturer’s statement that the device complies with Australian regulations.
• Product Information: This includes labelling, instructions for use, and information about the device’s purpose and unique identifier.
• Clinical Evidence (for most devices): This shows the device meets essential safety and performance standards.
• Link for more details

Registration Timeline

• Class I sterile or measuring function – 4 weeks
• Class I other (excluding export only devices) – Same Day
• Class IIa – 4 weeks
• Class IIb – 6 weeks
• Class III – 6 months (including application audit)

Registration Fee

Fees and Charges Summary

License Validity

Annual fees need to be paid to keep validity

License Renewal

3 Months before expiry date

Special Labelling Requirements

Labelling    should be in English. The Sponsor’s name and information must be included in the labelling.

Who should make this Communication?

• Manufacturer
• Authorized  Representative
  

When to make this Communication?

Before placing a medical device into the market.

What Counts as a Medical Device: The Software and AI Clarification

This is a genuinely important, recently clarified area worth understanding precisely: TGA has confirmed that software and AI tools — including clinical decision support tools and digital scribes that suggest diagnoses or treatments — may qualify as medical devices requiring ARTG inclusion. The determining test is functional: software is regulated as a medical device when it performs functions like diagnosis, treatment, or influencing clinical decisions based on patient-specific data. Software used purely for general wellness, administrative purposes, or displaying non-clinical information that doesn't impact patient care is not regulated this way. For digital health, AI-driven diagnostic, and software-enabled monitoring companies specifically, this classification boundary is worth assessing early and explicitly, since misjudging it carries real regulatory and commercial consequences — enforcement action, market withdrawal, or commercialization delays.

The Australian Sponsor: A Mandatory, Accountable Role

Foreign manufacturers without an Australian legal presence must appoint an Australian Sponsor — an Australia-based individual or incorporated entity. This is the only way to apply for TGA registration or supply locally; there's no alternative pathway. The Sponsor's details appear on the device label and ARTG certificate, reflecting a formal, accountable role rather than administrative support. January 2026 TGA guidance reinforced sponsor obligations specifically: sponsors are accountable for ensuring every device they import, export, or supply is ARTG-included (misunderstanding the sponsor role is explicitly not an acceptable defense against non-compliance), must maintain continuous access to technical documentation and conformity evidence, and — in a notable 2026 expansion — health professionals can themselves be considered suppliers under Australian law in certain clinical settings, extending ARTG-inclusion obligations further than some manufacturers might assume.

Two Main Registration Routes

TGA Conformity Assessment Route: the Sponsor submits a complete application via the TGA Business Services (TBS) Portal. This requires a full TGA conformity assessment confirming an appropriate , Essential Principles compliance, QMS support and TGA safety/performance criteria. Documentation includes a TGA-compliant technical dossier, TGA Conformity Assessment Certificate (CAC), Manufacturer Evidence, and clinical evidence.

Comparable Overseas Regulator (COR) Evidence Abridged Route (available across all classes)

leverages prior approval from a recognized reference market — EU Notified Bodies (CE), the US FDA, Japan's PMDA, Health Canada, Singapore's HSA, or MDSAP Auditing Organizations. Documentation includes the technical dossier, Manufacturer Evidence, Essential Principles conformity proof, a Declaration of Conformity, and proof of the underlying reference market approval.

Manufacturer Evidence: A Required Pre-Step

Before applying for ARTG inclusion (except for Class I devices, where a simple Declaration of Conformity suffices), you must first submit a Manufacturer Evidence (ME) application through the TGA Business Portal and obtain an ME Identifier — proof of an appropriate QMS and applicable certification (overseas regulator QMS evidence, CE certification, or a TGA CAC). This is a genuine prerequisite step, not something bundled automatically into the main ARTG application.

MDSAP: A Genuinely Efficient Conformity Pathway

Worth knowing as a real efficiency: Australia is one of five participating regulatory authorities in the Medical Device Single Audit Program (MDSAP), and TGA accepts MDSAP audit reports as conformity assessment evidence. Where an MDSAP audit specifically includes Australia, the auditing organization assesses your QMS against both    ISO 13485:2016   and TGA-specific requirements layered on top — an MDSAP certificate covering Australia functions similarly to an EU Notified Body certificate for ARTG purposes.

Audit Requirements by Risk Class

Higher-risk products (Class III and AIMD) face mandatory Level 2 audits, with required information due within 20 working days of TGA's request. Level 1 application audits are determined case-by-case — not automatic for any specific class, but a genuine possibility worth preparing for regardless of risk tier.The TGA may conduct an application audit before including a medical device in the ARTG. Applications may undergo either a Level 1 or Level 2 audit, depending on the device, applicable legislation, and the TGA's risk-based assessment.

Level 1 Audit

: Reviews administrative and regulatory documentation, such as conformity assessment evidence, labelling, and Instructions for Use (IFU).

Level 2 Audit

: Involves a more detailed assessment of   technical documentation, including clinical evidence, software, engineering, or other specialist information, where applicable.

If selected for an audit, applicants must provide the requested information within the timeframe specified by the TGA.

Processing Realistic Timeframeslines

Indicative processing times vary according to the device classification and complexity of the application. As a general guide, Class I and Class IIa applications may be processed in approximately 4 weeks, Class IIb applications in around 6 weeks, while Class III and Active Implantable Medical Device (AIMD) applications may require approximately 6 months. Actual processing times depend on factors such as application completeness, whether an application audit is required, and the time taken to respond to TGA requests for additional information. Applicants should refer to the latest TGA guidance and performance reports for current processing timeframes.Class I and IIa devices generally process in about 4 weeks, Class IIb in about 6 weeks; Class III and Active Implantable Medical Devices need approximately 6 months. The general statutory rule: TGA informs the applicant of its decision within 20 business days of the applicable fee payment — though this is the decision-notification timeline specifically, not necessarily the full review-to-approval timeline for higher-complexity applications.

ARTG Listings Don't Expire, But Require Active Maintenance

Worth understanding clearly: ARTG listings themselves don't expire, but require an annual maintenance fee, and TGA Conformity Assessment Certificates specifically must be renewed every five years. Treating ARTG inclusion as a permanent, set-and-forget status — rather than an ongoing compliance relationship with annual and five-year touchpoints — is a common, avoidable oversight.

Sponsor Transfers: Plan the Timing Carefully

Changing your Australian Sponsor requires a formal transfer application incurring fees and administrative effort — and transfer requests should be lodged before 30 June specifically, to avoid the outgoing sponsor incurring that year's annual charges under their name. This is a precise, date-sensitive detail worth building into any sponsor-transition planning.If a manufacturer wishes to appoint a different Australian Sponsor, the existing ARTG entry must be transferred in accordance with TGA requirements. Sponsor transfers should be planned carefully to ensure continuity of ARTG inclusion, Manufacturer Evidence, and supply of the medical device. Although there is no fee solely for notifying a sponsor transfer, additional fees may apply where associated changes to Manufacturer Evidence or ARTG entries are required.

Real Consequences for Non-Compliance

Worth stating plainly: non-compliance carries genuine consequences — civil sanctions and infringement notices, criminal prosecution in the most severe cases (including deliberate supply of unregistered devices), ARTG suspension or cancellation (immediately removing legal supply status), and public disclosure of compliance actions and enforcement outcomes on TGA's website, creating real reputational risk for non-compliant sponsors.

How OMC Medical can assist you with the process?

OMC Medical   acts as Australian Sponsor for foreign manufacturers, manages Manufacturer Evidence applications and ARTG submissions through both the TGA Conformity Assessment and Abridged routes, confirms whether software or AI-enabled products meet TGA's functional medical device test, and tracks the imminent 1 July 2026 reclassification deadline for affected ARTG entries.

• Act as your Authorized representative

Why Choose Us?

• Working towards client satisfaction
• Cost effective solutions
• Project completion before deadline
• Quality Regulatory affairs solutions

Contact us for free consultation:  sales@omcmedical.com